Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.
To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.
Please help improve GET-Evidence by evaluating evidence for this variant!
You are viewing an old version of this page that was saved on May 16, 2010 at 8:02pm by PharmGKB Importing Robot.
Insufficiently evaluated pharmacogenetic
(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)
Summary of published research, and additional commentary
Added in this revision:
Chung JY, Cho JY, Yu KS, Kim JR, Jung HR, Lim KS, Jang IJ, Shin SG. Effect of
the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug
interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther.
2005 Jun;77(6):486-94. PubMed PMID: 15961980.